Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹21 Cr₹25 Cr₹-69 Cr₹-136 Cr₹38 Cr

What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES is ₹21 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹21 Cr
Mar2025₹25 Cr
Mar2024₹-69 Cr
Mar2023₹-136 Cr
Mar2022₹38 Cr

How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹21 Cr
-15.97
Mar2025 ₹25 Cr
Positive
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹-136 Cr
Negative
Mar2022 ₹38 Cr -

Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹26,013.6 Cr 2.3% -5.4% 14.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

2.3%

-5.4%

14.8%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses